IMR Press / EJGO / Volume 19 / Issue 6 / pii/1998229

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Primary hormonal treatment for early endometrial carcinoma

Show Less
1 Gynecologic Oncology Unit, General Jose de San Martin Hospital, Buenos Aires University, Buenos Aires, Argentina
Eur. J. Gynaecol. Oncol. 1998, 19(6), 565–568;
Published: 10 December 1998

Four cases of clinical Stage I endometrial carcinoma initially treated with hormonal therapy are included in this study. Three of them resulted in tumor regression and two of them permitted a subsequent three pregnancies. All patients are alive and without evi­dence of disease with a median follow-up of 35.7 months (range 17 to 72 months). We believe this is a promising approach through which we may be able to offer a conservative treatment maintaining high sur­vival rates and preserving childbearing potential. Diagnostic and therapeutic data for fertility-desiring patients with endometrial car­cinoma are analyzed in this study.

Endometrial cancer
Hormonal Treatment
Back to top